Salim Yazji is Chief Medical Officer of Oncternal Therapeutics, Inc.. Currently has a direct ownership of 128,635 shares of ONCT, which is worth approximately $146,643. The most recent transaction as insider was on Jan 03, 2024, when has been sold 19,742 shares (Common Stock) at a price of $0.5 per share, resulting in proceeds of $9,871. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K
0% 3M change
13.31% 12M change
Total Value Held $146,643

Salim Yazji Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2024
SELL
Payment of exercise price or tax liability
$9,871 $0.5 p/Share
19,742 Reduced 13.31%
128,635 Common Stock
Jul 03 2023
SELL
Payment of exercise price or tax liability
$5,867 $0.36 p/Share
16,299 Reduced 9.9%
148,377 Common Stock
Apr 14 2023
BUY
Open market or private purchase
$1,500 $0.3 p/Share
5,000 Added 2.95%
164,676 Common Stock
Apr 13 2023
BUY
Open market or private purchase
$2,800 $0.28 p/Share
10,000 Added 5.89%
159,676 Common Stock
Apr 12 2023
BUY
Open market or private purchase
$2,800 $0.28 p/Share
10,000 Added 6.26%
149,676 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$10,160 $1.02 p/Share
9,961 Reduced 6.66%
139,676 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
82,500 Added 35.54%
149,637 Common Stock
Jan 27 2022
BUY
Open market or private purchase
$16,900 $1.69 p/Share
10,000 Added 12.96%
67,137 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
57,137 Added 50.0%
57,137 Common Stock
SY

Salim Yazji

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on ONCT

Follow Oncternal Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONCT shares.

Notify only if

Insider Trading

Get notified when an Oncternal Therapeutics, Inc. insider buys or sells ONCT shares.

Notify only if

News

Receive news related to Oncternal Therapeutics, Inc.

Track Activities on ONCT